These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

700 related items for PubMed ID: 16598792

  • 1. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis.
    Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, La Barba G, Zanello M, Grazi GL, Pinna AD.
    Liver Transpl; 2006 Jun; 12(6):966-71. PubMed ID: 16598792
    [Abstract] [Full Text] [Related]

  • 2. Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease.
    Cucchetti A, Ercolani G, Cescon M, Ravaioli M, Zanello M, Del Gaudio M, Lauro A, Vivarelli M, Grazi GL, Pinna AD.
    J Am Coll Surg; 2006 Nov; 203(5):670-6. PubMed ID: 17084328
    [Abstract] [Full Text] [Related]

  • 3. Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.
    Teh SH, Sheppard BC, Schwartz J, Orloff SL.
    Am J Surg; 2008 May; 195(5):697-701. PubMed ID: 18367132
    [Abstract] [Full Text] [Related]

  • 4. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Kim YJ, Yoon JH, Lee HS, Lee KU.
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [Abstract] [Full Text] [Related]

  • 5. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators.
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [Abstract] [Full Text] [Related]

  • 6. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure.
    Wang ZX, Yan LN, Wang WT, Xu MQ, Yang JY.
    Transplant Proc; 2007 Jun; 39(5):1501-4. PubMed ID: 17580172
    [Abstract] [Full Text] [Related]

  • 7. [The correlation of Child-Pugh score, PGA index and MELD score in the patient with liver cirrhosis and hepatocellular carcinoma according to the cause of alcohol and hepatitis B virus].
    Mun BS, Ahn HS, Ahn DS, Lee SO.
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):107-15. PubMed ID: 12824750
    [Abstract] [Full Text] [Related]

  • 8. The model for end-stage liver disease (MELD) predicts survival of liver cirrhosis patients after discharge to hospice.
    Antaki F, Lukowski A.
    J Clin Gastroenterol; 2007 Apr; 41(4):412-5. PubMed ID: 17413612
    [Abstract] [Full Text] [Related]

  • 9. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH, Liu HB, Wang Y, Wang BY, Song M, Sun MJ.
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
    [Abstract] [Full Text] [Related]

  • 10. Is portal hypertension a contraindication to hepatic resection?
    Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, Ramacciato G, Grazi GL, Pinna AD.
    Ann Surg; 2009 Dec; 250(6):922-8. PubMed ID: 19855258
    [Abstract] [Full Text] [Related]

  • 11. Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables.
    Cescon M, Cucchetti A, Grazi GL, Ferrero A, Viganò L, Ercolani G, Zanello M, Ravaioli M, Capussotti L, Pinna AD.
    Arch Surg; 2009 Jan; 144(1):57-63; discussion 63. PubMed ID: 19153326
    [Abstract] [Full Text] [Related]

  • 12. Selecting a short-term prognostic model for hepatocellular carcinoma: comparison between the model for end-stage liver disease (MELD), MELD-sodium, and five cancer staging systems.
    Huo TI, Hsia CY, Huang YH, Lin HC, Lee PC, Lui WY, Chiang JH, Chiou YY, Loong CC, Lee SD.
    J Clin Gastroenterol; 2009 Sep; 43(8):773-81. PubMed ID: 19262404
    [Abstract] [Full Text] [Related]

  • 13. Management of cirrhotic patients with blunt abdominal trauma: analysis of risk factor of postoperative death with the Model for End-Stage Liver Disease score.
    Lin BC, Fang JF, Wong YC, Hwang TL, Hsu YP.
    Injury; 2012 Sep; 43(9):1457-61. PubMed ID: 21511254
    [Abstract] [Full Text] [Related]

  • 14. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
    Huo TI, Lin HC, Hsia CY, Huang YH, Wu JC, Chiang JH, Chiou YY, Lui WY, Lee PC, Lee SD.
    Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
    [Abstract] [Full Text] [Related]

  • 15. Limitation of the model for end-stage liver disease for outcome prediction in patients with cirrhosis-related complications.
    Huo TI, Lin HC, Wu JC, Hou MC, Lee FY, Lee PC, Chang FY, Lee SD.
    Clin Transplant; 2006 Nov; 20(2):188-94. PubMed ID: 16640525
    [Abstract] [Full Text] [Related]

  • 16. Model for end-stage liver disease (MELD) score as a useful prognostic marker in cirrhotic patients with infection.
    Khan R, Abid S, Jafri W, Awan S, Hamid S, Shah H, Pervez S.
    J Coll Physicians Surg Pak; 2009 Nov; 19(11):694-8. PubMed ID: 19889264
    [Abstract] [Full Text] [Related]

  • 17. [New scoring systems for severity outcome of liver cirrhosis and hepatocellular carcinoma: current issues concerning the Child-Turcotte-Pugh score and the Model of End-Stage Liver Disease (MELD) score].
    Lee DH, Son JH, Kim TW.
    Taehan Kan Hakhoe Chi; 2003 Sep; 9(3):167-79. PubMed ID: 14515034
    [Abstract] [Full Text] [Related]

  • 18. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score.
    Huo TI, Lin HC, Lee FY, Hou MC, Lee PC, Wu JC, Chang FY, Lee SD.
    Liver Int; 2006 Feb; 26(1):55-61. PubMed ID: 16420510
    [Abstract] [Full Text] [Related]

  • 19. Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy.
    Huo TI, Wu JC, Lin HC, Lee FY, Hou MC, Huang YH, Lee PC, Chang FY, Lee SD.
    Liver Transpl; 2004 Dec; 10(12):1507-13. PubMed ID: 15558587
    [Abstract] [Full Text] [Related]

  • 20. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients.
    Farnsworth N, Fagan SP, Berger DH, Awad SS.
    Am J Surg; 2004 Nov; 188(5):580-3. PubMed ID: 15546574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.